Meta Pixel

News and Announcements

Atomo Diagnostics Annual Update 2015; Secures Commitments for Over US$8m

  • Published December 15, 2015 2:13PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
  • Atomo Diagnostics secures commitments for over US$8 million to support continued global rollout
  • Atomo has executed a Term Sheet with a leading Global Impact Fund and received preliminary board approval from the fund for an investment totalling US$8million. The investment, a combination of a loan and equity, will be used to scale up of Atomo’s manufacturing capabilities.
  • Additionally, Atomo was awarded a grant of A$1.8 million from the NSW Medical Device Fund to commercialise a HIV self-test solution. To complete its capital activity, Atomo is seeking up to US$4 million in additional equity and intends to finalise the capital raise by February 1, 2016.

ABOUT ATOMO DIAGNOSTICS

Atomo Diagnostics is an emerging and multi-award winning medical devices company that has commercialised AtomoRapid™, the world’s first ever integrated rapid blood test. AtomoRapid™ makes obsolete longstanding “bits in a box” test kits. Improved safety, reliability and convenience with AtomoRapid™ results in overwhelming user preference.

Atomo is proving its commercial success, satisfying export driven demand for HIV, Malaria and Ebola. Atomo’s continued growth across diagnostic markets include a self-test solution targeting growing consumer markets, with Atomo agreeing to work with a global pharmaceutical company to launch and distribute Atomo’s consumer test range in Australia and New Zealand.

Capital Insights
The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Join over 45,000+ sophisticated investors

Join Now